50603-99-1

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 3-(1-Bromomethyl)benzoate is used as an intermediate in the synthesis of pharmaceuticals for its ability to react with other compounds to form new molecules with potential therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, Methyl 3-(1-Bromomethyl)benzoate serves as an intermediate in the production of various agrochemicals, contributing to the development of new compounds for crop protection and enhancement of agricultural productivity.
Used in Organic Synthesis:
Methyl 3-(1-Bromomethyl)benzoate is utilized in organic synthesis as a versatile reagent, enabling the formation of a wide range of organic compounds through its reactivity with other molecules.
Used as a Reagent in Chemical Reactions:
As a reagent in chemical reactions, Methyl 3-(1-Bromomethyl)benzoate plays a crucial role in facilitating specific transformations and reactions, contributing to the advancement of chemical research and the development of new compounds with diverse applications.

Upstream product

• 21860-07-1 methyl 3-acetylbenzoate 
• 586-42-5 3-acetylbenzoic acid 
• 87808-11-5 methyl 3-(1-hydroxyethyl)benzenecarboxylate 
• 7789-60-8 phosphorus tribromide 

Downstream Products

• 1353657-65-4 rac-methyl 3-[1-({6-amino-3,5-dicyano-4-[4-(2-methoxyethoxy)phenyl]pyridin-2-yl}sulfanyl)-ethyl]benzenecarboxylate 
• 1353657-64-3 rac-methyl 3-[(1-{6-amino-3,5-dicyano-4-[4-(2-hydroxyethoxy)phenyl]pyridin-2-yl}sulfanyl)-ethyl]benzenecarboxylate 
• 1353656-34-4 rac-3-[(1S)-1-({6-amino-3,5-dicyano-4-[4-(2-hydroxyethoxy)phenyl]pyridin-2-yl}sulfanyl)-ethyl]benzenecarboxylic acid 
• 1353656-77-5 rac-3-[1-({6-amino-3,5-dicyano-4-[4-(2-hydroxyethoxy)phenyl]pyridin-2-yl}sulfanyl)ethyl]-benzenecarboxamide 
• 1353656-78-6 rac-3-[1-({6-amino-3,5-dicyano-4-[4-(2-hydroxyethoxy)phenyl]pyridin-2-yl}sulfanyl)ethyl]-N-methylbenzenecarboxamide 
• 1182333-49-8 Methyl 3-[1-({6-amino-3,5-dicyano-4-[4-(tetrahydrofuran-3-yloxy)phenyl]pyridin-2-yl}sulfanyl)ethyl]benzoate 

Relevant academic research and scientific papers

Method for synthesizing alkyne through catalytic asymmetric cross coupling (by machine translation)

The invention belongs to the field of, asymmetric synthesis, and discloses a method for catalyzing asymmetric cross- coupling to synthesize: an alkyne, and the L method comprises, the following steps, of A: preparing B a cuprous, salt and C a: ligand; preparing a catalyst; adding a base; reacting the compound with the compound with the compound; and reacting the compound with the compound. Of these, one of them, X is selected from the group consisting of, R halogens. 1 Optionally substituted heteroarylsulfonylcyanamide groups selected from the, group consisting, of optionally substituted, phenyl groups In-flight vehicle, R6 Trialkyl silyl groups or alkyl radicals, R2 Cycloalkyl radicals optionally substituted with an, optionally substituted alkyl, (CH radical2 )n R4 Multi,layer chain, n＝0-10,R saw blade4 A group selected, from, the group consisting of phenyl, alkenyl, aralkynyls, noonyloxy,and, noonylsulfonylsulfonylsulfonylsulfonylsulfonylsulfonylsulfonylsulfonylsulfonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylsulphonylphenyl disiloxy-radicals. R3 A ligand, selected from hydrogen or any of the functional groups, is selected from the group consisting of, hydrogen and any L other functional group. The method, R disclosed by the, A invention has the, advantages of good catalytic, R ’ effect, wide application range. and high catalytic efficiency, and the, method disclosed by the, invention has the. advantages of good catalytic effect, wide application range and high catalytic efficiency. (by machine translation)

SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF

The present application relates to novel substituted dicyanopyridines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, preferably for the treatment and/or prophylaxis of cardiovascular disorders.

Pharmaceutically active phenylcarboxylic acid derivatives

Compounds which antagonize the slow-reacting substance of anaphylaxis or components thereof, e.g., leukotrienes, in warm blooded animals as well as intermediates and methods for their preparation, pharmaceutical compositions and methods for their administration. The compounds are diphenyl carboxylic acids with particular linking groups between the individual phenyl rings and the carboxylic acid moiety. Particular utilities are to relieve asthma and inflammation in man.